查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529847

分子影像市场规模、份额、趋势分析报告：按模式、应用、最终用途、地区和细分市场预测，2024-2030 年

Molecular Imaging Market Size, Share & Trends Analysis Report By Modality (SPECT, NMR), By Application (Oncology, Cardiology), By End-use (Hospitals, Diagnostic Imaging Centers), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 220 Pages | 商品交期: 2-10个工作天内

价格

分子影像市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球分子影像市场规模将达到114.4亿美元，2024年至2030年复合年增长率为4.52%。

市场成长的主要因素包括技术进步、癌症盛行率的增加以及研发投资的增加。例如，根据国际癌症研究机构的数据，2022 年全球将报告约 19,976,499 例新癌症病例和 9,743,832 例癌症相关死亡。

癌症、心血管疾病和神经系统疾病等慢性疾病的盛行率不断上升，需要有效的诊断工具，预计将显着促进分子影像市场的成长。 PET（正子断层扫描）、SPECT（单光子发射电脑断层扫描）和 NMR（核磁共振）光谱仪等分子影像仪器在这方面特别有效。这些先进技术提供了对与各种疾病相关的代谢过程、分子活动和结构变化的详细了解。这些使医疗保健专业人员能够高精度地可视化和评估肿瘤的范围和特征、心臟功能和神经系统异常。

此外，分子影像有助于疾病的早期发现，甚至在亚临床阶段，从而可以及时干预和个人化治疗计划。这种积极主动的方法不仅可以改善患者的治疗效果，还可以降低与晚期疾病阶段和併发症相关的医疗费用。

主要市场参与者采取的策略性倡议，如併购、产品发布、监管核准、联盟、合作以及研发 (R&D) 活动在推动分子影像市场的成长中发挥关键作用。例如，2024 年 1 月，布鲁克公司在俄亥俄州立大学国家门户超高场核磁共振中心成功安装了最先进的 1.2吉赫(GHz) 核磁共振系统。这种 GHz 级 NMR 系统代表了核磁共振 (NMR) 波谱学的重大进步，旨在彻底改变生命科学和材料科学研究。

分子成像市场报告亮点

  • 按模式划分，单光子放射电脑断层扫描 (SPECT) 领域将在 2023 年占据主导地位，份额为 43.8%。
  • 核磁共振 (NMR) 波谱仪领域预计从 2024 年到 2030 年将以最快的复合年增长率成长。
  • 按应用划分，肿瘤学领域占据最大的市场占有率，2023 年份额为 33.7%。
  • 按最终用途划分，到 2023 年，医院领域将占据市场的大部分份额。
  • 诊断成像中心领域预计将从 2024 年到 2030 年以最快的速度成长。
  • 2023年北美占41.7%的份额。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章分子影像市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 分子影像市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章分子影像市场：依模态估计与趋势分析

  • 细分仪表板
  • 依方式分析全球分子影像市场变化
  • 2018-2030 年全球分子影像市场规模与趋势分析（按模式）
  • 分子超音波成像
  • 正子断层扫描 (PET)
  • 单光子发射电脑断层扫描 (SPECT)
  • 核磁共振 (NMR) 波谱仪
  • 其他方式

第五章分子影像市场：按应用估计和趋势分析

  • 细分仪表板
  • 全球分子影像市场按应用变化分析
  • 2018-2030年全球分子影像市场规模及趋势分析（依应用）
  • 心血管
  • 神经病学
  • 肿瘤学
  • 呼吸系统
  • 胃肠道

第六章分子影像市场：最终用途的估计和趋势分析

  • 细分仪表板
  • 按最终用途分類的全球分子成像市场变化分析
  • 2018-2030 年全球分子影像市场规模与趋势分析（依最终用途）
  • 医院
  • 影像诊断中心
  • 调查机构

第七章分子影像市场：按应用和最终用途的区域估计和趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 2023年主要企业市场占有率分析
  • 公司定位分析
  • 公司分类（新兴企业、创新企业、领导者）
  • 公司简介
    • Bruker
    • GE HealthCare
    • Siemens Healthineers
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Mediso, Cubresa Inc.
    • Shimadzu Corporation
    • United Imaging Healthcare Co
    • Positron Corporation
Product Code: GVR-4-68040-374-6

Molecular Imaging Market Growth & Trends:

The global molecular imaging market size is anticipated to reach USD 11.44 billion by 2030, growing at a CAGR of 4.52% from 2024 to 2030, according to a new report by Grand View Research, Inc. The major factors contributing to market growth include technological advancements, increase in prevalence of cancer, and rising investment in R&D. For instance, according to the International Agency for Research on Cancer, approximately 19,976,499 new cancer cases and 9,743,832 cancer-related deaths were reported globally in 2022.

The growing prevalence of chronic disorders such as cancer, cardiovascular diseases, and neurological conditions necessitates effective diagnostic tools, which are expected to significantly contribute to the growth of the molecular imaging market. Molecular imaging devices such as PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography), and Nuclear Magnetic Resonance (NMR) Spectrometer are particularly efficient in this regard. These advanced technologies provide detailed insights into the metabolic processes, molecular activities, and structural changes associated with various diseases. They enable healthcare professionals to visualize and assess the extent and characteristics of tumors, cardiac function, and neurological abnormalities with high precision and accuracy.

Moreover, molecular imaging facilitates early detection of diseases, even at subclinical stages, allowing for timely intervention and personalized treatment planning. This proactive approach not only improves patient outcomes but also reduces healthcare costs associated with advanced disease stages and complications.

Strategic initiatives undertaken by major market players, including mergers and acquisitions, product launches, regulatory approvals, partnerships, collaborations, and research and development (R&D) activities, play a crucial role in driving the growth of the molecular imaging market. For instance, in January 2024, Bruker Corporation successfully installed a state-of-the-art 1.2 Gigahertz (GHz) NMR system at The Ohio State University's National Gateway Ultrahigh Field NMR Center. This GHz-class NMR system represents a significant advancement in nuclear magnetic resonance (NMR) spectroscopy, aiming to revolutionize research in life sciences and materials science.

Molecular Imaging Market Report Highlights:

  • Based on the modality segment, the Single Photon Emission Computed Tomography (SPECT) segment dominated by capturing a share of 43.8% in 2023
  • The Nuclear Magnetic Resonance (NMR) Spectrometer segment is anticipated to grow at the fastest CAGR from 2024 to 2030
  • Based on application, the oncology segment held the largest market share in the application segment by capturing a share of 33.7% in 2023.
  • Based on end use, the hospital segment held a majority share of the market in 2023.
  • Diagnostic imaging centers segment is expected to grow at the fastest rate from 2024 to 2030
  • North America dominated the market with a share of 41.7% in 2023.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Modality
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Modality outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Molecular Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of cancer and other chronic diseases
      • 3.2.1.2. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Cost of Equipment and Treatment
  • 3.3. Molecular Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Molecular Imaging Market: Modality Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Molecular Imaging Modality Market Movement Analysis
  • 4.3. Global Molecular Imaging Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
  • 4.4. Molecular Ultrasound Imaging
    • 4.4.1. Molecular ultrasound imaging market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Positron Emission Tomography (PET)
    • 4.5.1. Positron emission tomography (PET) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Single Photon Emission Computed Tomography (SPECT)
    • 4.6.1. Single photon emission computed tomography (SPECT) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Nuclear Magnetic Resonance (NMR) Spectrometer
    • 4.7.1. Nuclear Magnetic resonance (NMR) spectrometer market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Other Modalities
    • 4.8.1. Other modalities market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Molecular Imaging Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Molecular Imaging Application Market Movement Analysis
  • 5.3. Global Molecular Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Cardiovascular
    • 5.4.1. Cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Neurology
    • 5.5.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Oncology
    • 5.6.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Respiratory
    • 5.7.1. Respiratory market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Gastrointestinal
    • 5.8.1. Gastrointestinal market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Molecular Imaging Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Molecular Imaging End Use Market Movement Analysis
  • 6.3. Global Molecular Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Diagnostic Imaging Centers
    • 6.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Research institutes
    • 6.6.1. Research institutes market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Molecular Imaging Market: Regional Estimates & Trend Analysis By Application, End Use

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Competitive scenario
      • 7.5.1.3. Regulatory framework
      • 7.5.1.4. Reimbursement structure
      • 7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Reimbursement structure
      • 7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Reimbursement structure
      • 7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Competitive scenario
      • 7.6.1.3. Regulatory framework
      • 7.6.1.4. Reimbursement structure
      • 7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement structure
      • 7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement structure
      • 7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Reimbursement structure
      • 7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Reimbursement structure
      • 7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. Reimbursement structure
      • 7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework
      • 7.6.7.4. Reimbursement structure
      • 7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Competitive scenario
      • 7.6.8.3. Regulatory framework
      • 7.6.8.4. Reimbursement structure
      • 7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement structure
      • 7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement structure
      • 7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement structure
      • 7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement structure
      • 7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement structure
      • 7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Regulatory framework
      • 7.7.6.4. Reimbursement structure
      • 7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement structure
      • 7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement structure
      • 7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement structure
      • 7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement structure
      • 7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Competitive scenario
      • 7.9.3.3. Regulatory framework
      • 7.9.3.4. Reimbursement structure
      • 7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Competitive scenario
      • 7.9.4.3. Regulatory framework
      • 7.9.4.4. Reimbursement structure
      • 7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market share analysis, 2023
  • 8.4. Company Position Analysis
  • 8.5. Company Categorization (Emerging Players, Innovators and Leaders
  • 8.6. Company Profiles
    • 8.6.1. Bruker
      • 8.6.1.1. Company overview
      • 8.6.1.2. Financial performance
      • 8.6.1.3. Product benchmarking
      • 8.6.1.4. Strategic initiatives
    • 8.6.2. GE HealthCare
      • 8.6.2.1. Company overview
      • 8.6.2.2. Financial performance
      • 8.6.2.3. Product benchmarking
      • 8.6.2.4. Strategic initiatives
    • 8.6.3. Siemens Healthineers
      • 8.6.3.1. Company overview
      • 8.6.3.2. Financial performance
      • 8.6.3.3. Product benchmarking
      • 8.6.3.4. Strategic initiatives
    • 8.6.4. Koninklijke Philips N.V.
      • 8.6.4.1. Company overview
      • 8.6.4.2. Financial performance
      • 8.6.4.3. Product benchmarking
      • 8.6.4.4. Strategic initiatives
    • 8.6.5. Canon Medical Systems Corporation
      • 8.6.5.1. Company overview
      • 8.6.5.2. Financial performance
      • 8.6.5.3. Product benchmarking
      • 8.6.5.4. Strategic initiatives
    • 8.6.6. Mediso, Cubresa Inc.
      • 8.6.6.1. Company overview
      • 8.6.6.2. Financial performance
      • 8.6.6.3. Product benchmarking
      • 8.6.6.4. Strategic initiatives
    • 8.6.7. Shimadzu Corporation
      • 8.6.7.1. Company overview
      • 8.6.7.2. Financial performance
      • 8.6.7.3. Product benchmarking
      • 8.6.7.4. Strategic initiatives
    • 8.6.8. United Imaging Healthcare Co
      • 8.6.8.1. Company overview
      • 8.6.8.2. Financial performance
      • 8.6.8.3. Product benchmarking
      • 8.6.8.4. Strategic initiatives
    • 8.6.9. Positron Corporation
      • 8.6.9.1. Company overview
      • 8.6.9.2. Financial performance
      • 8.6.9.3. Product benchmarking
      • 8.6.9.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America molecular imaging market, By country, 2018 - 2030 (USD Million)
  • Table 4 North America molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 5 North America molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 6 North America molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 7 U.S. molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 8 U.S. molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 9 U.S. molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 11 Canada molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 12 Canada molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 13 Mexico molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 14 Mexico molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 15 Mexico molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 16 Europe molecular imaging market, By country, 2018 - 2030 (USD Million)
  • Table 17 Europe molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 18 Europe molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 19 Europe molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 20 UK molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 21 UK molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 22 UK molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 23 Germany molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 24 Germany molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 25 Germany molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 26 France molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 27 France molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 28 France molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 29 Italy molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 30 Italy molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 31 Italy molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 32 Denmark molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 33 Denmark molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 34 Denmark molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 35 Sweden molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 36 Sweden molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 37 Sweden molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 38 Norway molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 39 Norway molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 40 Norway molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific molecular imaging market, By country, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 45 Japan molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 46 Japan molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 47 Japan molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 48 China molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 49 China molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 50 China molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 51 India molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 52 India molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 53 India molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 54 Australia molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 55 Australia molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 56 Australia molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 57 South Korea molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 58 South Korea molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 59 South Korea molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 60 Thailand molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 61 Thailand molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 62 Thailand molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 63 Latin America molecular imaging market, By Country, 2018 - 2030 (USD Million)
  • Table 64 Latin America molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 65 Latin America molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 66 Latin America molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 67 Brazil molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 68 Brazil molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 69 Brazil molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 70 Argentina molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 71 Argentina molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 72 Argentina molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 73 Middle East & Africa molecular imaging market, By country, 2018 - 2030 (USD Million)
  • Table 74 Middle East & Africa molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 75 Middle East & Africa molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 76 Middle East & Africa molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 77 South Africa molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 78 South Africa molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 79 South Africa molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 83 UAE molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 84 UAE molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 85 UAE molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 86 Kuwait molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 87 Kuwait molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 88 Kuwait molecular imaging market, By end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Molecular Imaging market: market outlook
  • Fig. 14 Parent market outlook
  • Fig. 15 Related/ancillary market outlook
  • Fig. 16 Penetration and growth prospect mapping
  • Fig. 17 Industry value chain analysis
  • Fig. 18 Molecular imaging market driver impact
  • Fig. 19 Molecular imaging market restraint impact
  • Fig. 20 Molecular imaging market: Modality movement analysis
  • Fig. 21 Molecular imaging market: Modality outlook and key takeaways
  • Fig. 22 Molecular ultrasound imaging market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Positron emission tomography (PET) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Single photon emission computed tomography (SPECT) market estimates and forecast, 2018-2030 (USD Million)
  • Fig. 25 Nuclear magnetic resonance (NMR) spectrometer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Other modalities market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Molecular imaging market: Application movement analysis
  • Fig. 28 Molecular imaging market: Application outlook and key takeaways
  • Fig. 29 Cardiovascular market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Neurology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Respiratory market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Gastrointestinal market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Molecular imaging market: End use movement analysis
  • Fig. 35 Molecular imaging market: End use outlook and key takeaways
  • Fig. 36 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Diagnostic imaging centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Research institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Global molecular imaging market: Regional movement analysis
  • Fig. 40 Global molecular imaging market: Regional outlook and key takeaways
  • Fig. 41 North America
  • Fig. 42 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 U.S.
  • Fig. 44 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Canada
  • Fig. 46 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico
  • Fig. 48 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Europe
  • Fig. 50 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 UK
  • Fig. 52 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Germany
  • Fig. 54 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 France
  • Fig. 56 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Italy
  • Fig. 58 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Spain
  • Fig. 60 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Denmark
  • Fig. 62 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Sweden
  • Fig. 64 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Norway
  • Fig. 66 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Asia Pacific
  • Fig. 68 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 China
  • Fig. 70 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Japan
  • Fig. 72 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 India
  • Fig. 77 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Thailand
  • Fig. 76 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 South Korea
  • Fig. 78 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Australia
  • Fig. 80 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Latin America
  • Fig. 82 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Brazil
  • Fig. 84 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Mexico
  • Fig. 86 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Argentina
  • Fig. 88 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Middle East and Africa
  • Fig. 90 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 South Africa
  • Fig. 92 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Saudi Arabia
  • Fig. 94 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 UAE
  • Fig. 96 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Kuwait
  • Fig. 98 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Market share of key market players- Molecular imaging market